SCHEMBL31527934

SCHEMBL31527934

CC(=Cc1nc(-c2ccc(Oc3ccccn3)cc2F)no1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IP6K1 Q92551 2/20 0.39
▸ IP6K3 Q96PC2 2/20 0.39
▸ IP6K2 Q9UHH9 2/20 0.39
▸ SCN7A Q01118 2/20 0.36
▸ KCNH2 Q12809 2/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ HRH3 Q9Y5N1 6/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ HDAC5 Q9UQL6 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ DHODH Q02127 1/20 0.34
▸ BACE1 P56817 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31527878 0.90 DRD1 (0.42) IP6K1IP6K3IP6K2SCN7AKCNH2
SCHEMBL31527880 0.89 IP6K1 (0.39) IP6K1IP6K3IP6K2SCN7AKCNH2
SCHEMBL31527971 0.87 IP6K1 (0.38) IP6K1IP6K3IP6K2SCN7AKCNH2
SCHEMBL31527987 0.81 PDE4D (0.38) IP6K1IP6K3IP6K2HDAC6RXRA
SCHEMBL31527931 0.77 MAPT (0.42) IP6K1IP6K3IP6K2SCN7AKCNH2
SCHEMBL31528000 0.76 PDE4D (0.39) IP6K1IP6K3IP6K2MAPTDHODH
SCHEMBL31527917 0.76 PDE4D (0.40) IP6K1IP6K3IP6K2MAPTMEN1
SCHEMBL31527942 0.73 LMNA (0.42) PPARGMAPTLMNAMAPK1HTT
SCHEMBL31527936 0.72 PPARD (0.46) MAPTLMNAHTT
SCHEMBL31528002 0.70 LMNA (0.44) MAPTLMNAMAPK1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN claimed
Send feedback